Japan vs Singapore: Proportion of isolates with decreased susceptibility or resistance
Japan
3.7
in 2020
Singapore
2.2
in 2020
Japan rank
5th
Singapore rank
6th
Proportion of isolates with decreased susceptibility or resistance over time
- Japan
- Singapore
How they compare
Japan currently reports 3.7 against 2.2 in Singapore, a difference of 1.5.
That makes Japan's figure about 1.7 times Singapore's.
The two have swapped places 2 times across 11 shared years of data; in 2009 it was Japan ahead.
Japan ranks 5th and Singapore ranks 6th of 52 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.35 | 1.25 | 19.1 | Japan |
| 2010s | 14.95 | 2.43 | 12.52 | Japan |
| 2020s | 3.7 | 2.2 | 1.5 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Japan or Singapore?
- Japan, at 3.7 against 2.2 in Singapore as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Japan and Singapore?
- 1.5, with Japan ahead.
- How many years of comparable data are there for Japan and Singapore?
- 11 years are reported by both, from 2009 to 2020.
- How do Japan and Singapore rank globally for proportion of isolates with decreased susceptibility or resistance?
- Japan ranks 5th and Singapore ranks 6th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.